“Done” Health Federal Charges: When Social Media Drug Sales Went Wrong in California
Done Health founders Ruthia He and David Brody now face decades in federal prison after their conviction for orchestrating a $100 million Adderall distribution scheme through telemedicine. The case marks a significant turning point in federal enforcement against prescription drug fraud, particularly when conducted through digital platforms. Prosecutors demonstrated how the company targeted vulnerable patients through Instagram drug sales federal charges and similar social media tactics, creating an automated prescription mill that prioritized profit over patient safety. Anyone facing allegations involving online controlled substance distribution should consult a Snapchat drug dealing lawyer immediately, as federal penalties prove severe and consequences life-altering.
The Done Health Conviction: Key Facts and Timeline
What Led to the Federal Investigation
Wall Street Journal articles published in September 2022 triggered the federal scrutiny that ultimately dismantled Done Health's operations. The reporting described how clinicians at the company felt pressured to prescribe stimulants like Adderall, prompting DEA agents to launch an investigation into Done's practices for prescribing controlled substances. Media coverage wasn't the only red flag. Major pharmacy chains began blocking prescriptions written by Done-affiliated providers, raising concerns about the legitimacy of the telemedicine platform's clinical practices.
The investigation gained momentum as federal authorities examined how Done Global exploited COVID-19 emergency telehealth rules. Before the pandemic, prescriptions for Schedule II controlled substances like Adderall required in-person assessments. Done capitalized on temporary regulatory relaxations that allowed virtual patient visits for stimulant prescriptions. DEA Administrator Anne Milgram stated the defendants allegedly preyed on Americans by exploiting telemedicine rules that facilitated access to medications during the unprecedented COVID-19 public health emergency.
Federal prosecutors arrested Ruthia He and David Brody on June 13, 2024, announcing what the Justice Department described as its first criminal drug distribution prosecution tied to a digital health company's telemedicine prescribing model. The case proceeded to trial in October 2025 in the United States District Court for the Northern District of California.
The Verdict Against Ruthia He and David Brody
A federal jury in San Francisco convicted both defendants on November 18, 2025, finding them guilty on all charges. He and Brody each faced conviction on one count of conspiracy to distribute controlled substances, four counts of distribution of controlled substances, and one count of conspiracy to commit health care fraud. He received an additional conviction for one count of conspiracy to obstruct justice.
The convictions carry severe penalties. Both defendants face a maximum penalty of 20 years in prison on the conspiracy to distribute controlled substances and distribution of controlled substances counts. Sentencing is scheduled for February 25, 2026. During the trial, three individuals testified after pleading guilty to crimes arising from the same events involving Done Global, He, and Brody.
Criminal Charges Filed Against Done Global Inc.
Federal prosecutors didn't stop with the individual convictions. In December 2025, the Justice Department filed a superseding indictment adding Done Global and Mindful Mental Wellness P.A. (MMW), a Florida medical practice, as corporate defendants. The indictment alleged continued violations of federal controlled substances laws through February 2025.
Done Global faces charges including conspiracy to illegally distribute Adderall, four counts of illegal distribution of Adderall, conspiracy to commit health care fraud, and conspiracy to obstruct justice. If convicted, Done Global faces a maximum penalty of twice the gross profits or other proceeds for conspiracy and illegal distribution charges, plus twice the gain or twice the gross loss for conspiracy to commit health care fraud and obstruction. MMW faces a maximum penalty for conspiracy to illegally distribute Adderall of twice the gross profits or other proceeds.
Acting Assistant Attorney General Matthew R. Galeotti emphasized that Done Global used lies and deceit to carry out a sophisticated and wide-ranging telehealth fraud scheme, obtaining over $100 million in the process.
How the $100 Million Adderall Scheme Operated
Subscription-Based Telemedicine Model
Done Health built its revenue engine around a straightforward payment structure. Patients paid $299 upfront for an initial evaluation, followed by $79 monthly to maintain access to prescriptions and provider messaging. The company refused insurance, operating entirely on a cash-pay basis. This business model generated over $100 million in revenue while arranging prescriptions for more than 40 million pills of Adderall and other stimulants.
The subscription model created financial incentives that prosecutors argued drove inappropriate prescribing. More prescriptions translated directly into sustained monthly payments. Federal authorities alleged that Done Global instructed prescribers to approve stimulants even when patients didn't qualify, specifically to increase subscription revenue and boost the company's valuation.
Targeting Vulnerable Patients Through Social Media
Done Global spent more than $42 million running advertisements on social media platforms. These campaigns targeted individuals who may or may not have had legitimate medical needs for ADHD medication. The marketing emphasized ease and accessibility, promising quick online diagnosis, treatment, and medication refills for ADHD.
Social media proved particularly effective for reaching potential customers. Research shows that 69 percent of prescribers reported having patients ask about specific prescription drugs they saw on social media, with 61 percent subsequently prescribing the requested medication. Done capitalized on this dynamic, using platforms to drive patient demand for controlled substances.
Auto-Refill Technology and Prescription Automation
Prosecutors alleged that medications could be automatically refilled without follow-up visits, provided patients maintained their $79 monthly subscription fee. This automation removed a critical safeguarding mechanism. Traditional medical practice requires periodic reassessment before renewing controlled substance prescriptions. Done's system allegedly bypassed these checkpoints.
The company arranged prescriptions for Done members without pre-existing practitioner-patient relationships and sometimes without any video or audio communication at all. In some cases, prescriptions flowed based solely on limited patient intake documents.
Limiting Clinical Oversight and Appointment Times
Initial appointments lasted 30 minutes. Prosecutors alleged the vast majority of Done patients received stimulant prescriptions after completing brief online screening questions plus this single telehealth appointment. Federal authorities claimed Done provided few, if any, medical treatment options besides prescribing Adderall and other stimulants.
Clinical oversight proved insufficient according to the indictment. Some patients didn't meet DSM-V criteria for diagnosing ADHD. Others posed diversion risks. Done allegedly provided dosages, combinations, or quantities of medications beyond legitimate medical purpose and outside usual professional practice. The company operated 100,000 patients nationwide through this streamlined model.
Legal Violations That Brought Down Done Health
Federal prosecutors built their case against Done Health on multiple statutory violations that collectively demonstrated a systematic disregard for controlled substance regulations and patient safety.
Illegal Distribution of Controlled Substances
The Ryan Haight Online Pharmacy Consumer Protection Act establishes strict requirements for prescribing controlled substances via telemedicine. Federal law mandates that prescriptions for controlled substances be issued only for legitimate medical purposes by practitioners acting in their usual course of professional practice. The statute requires practitioners to conduct at least one in-person medical evaluation before prescribing controlled substances through telemedicine.
Done Global allegedly arranged prescriptions for members without pre-existing practitioner-patient relationships, without examinations, and sometimes without any video or audio communication. Prescriptions flowed based solely on short video calls and limited patient intake documents. Prosecutors alleged the conspiracy's purpose centered on unlawful enrichment by instructing prescribers to write stimulant prescriptions without legitimate medical purpose.
Health Care Fraud and Insurance Deception
He, Brody, and others submitted false prior authorization requests to Medicare, Medicaid, and commercial insurers. These requests falsely claimed Done followed DSM-5 diagnostic criteria, utilized urine drug screening to monitor prescription usage, and claimed non-stimulant treatments had been tried without success. None of these representations reflected actual practice.
The deception proved lucrative. Medicare, Medicaid, and commercial insurers paid Done more than approximately $14 million based on these fraudulent claims. Federal health care fraud statutes prohibit intentional deception to receive illegal benefits or payments from insurance programs.
Obstruction of Justice Tactics
After receiving a grand jury subpoena, He allegedly orchestrated a sophisticated obstruction campaign. Evidence at trial showed she relocated Done operations to China, making personnel and evidence unavailable to investigators. She transferred over $1 million to a Chinese shell company named Make Believe Asia.
Furthermore, He limited her communications on company platforms, switched to encrypted messaging apps with disappearing messages, and deleted incriminating documents. Prosecutors presented evidence that she conducted internet searches for countries without extradition treaties and was stopped by law enforcement while attempting to leave the country.
Prescribing Without Legitimate Medical Purpose
Federal regulations impose dual obligations on prescribers and pharmacists. A prescription issued outside the usual course of professional treatment fails to qualify as a legitimate prescription. Correspondingly, pharmacists bear responsibility for ensuring controlled substance prescriptions serve legitimate medical purposes.
Done allegedly provided few medical treatment options besides stimulants. Some patients didn't meet DSM-V criteria for ADHD diagnosis, posed diversion risks, or received dosages and combinations beyond legitimate medical purpose. The company prohibited practitioners from discharging patients even after learning of prescribing red flags, including patients abusing other medications and suffering from Adderall-induced psychosis.
The Human Cost: Patient Safety and Addiction
Federal prosecutors documented specific cases where Done Health's practices resulted in direct patient harm, moving beyond financial fraud to life-threatening consequences.
Cases of Adderall-Induced Psychosis
Some Done members suffered from Adderall-induced psychosis while under the company's care. The condition, characterized by hallucinations, paranoia, and severe psychological disturbance, represents one of the most serious adverse effects of stimulant abuse. Done's response to these medical emergencies proved particularly damning. The company prohibited practitioners from discharging patients even after learning about prescribing red flags, including those experiencing psychosis from the medications Done prescribed.
This policy created a dangerous cycle. Patients experiencing psychiatric emergencies continued receiving prescriptions for the very substances causing their symptoms. Practitioners who identified these problems faced corporate restrictions preventing them from taking appropriate medical action. The business model demanded patient retention regardless of clinical deterioration.
Prescriptions Issued to Deceased Patients
The problem of prescriptions flowing to inappropriate recipients extended beyond Done's operations into broader Medicare fraud patterns. A Health and Human Services Department inspector general report found Medicare paid for drugs for 158 beneficiaries after they were already dead. The program's rules allowed payment for prescriptions filled up to 32 days after a patient's death.
The cost reached $292,381, averaging $1,850 per deceased beneficiary. Investigators examining HIV medications found 348 prescriptions dispensed for dead beneficiaries in 2012 alone. Nearly half were filled more than a week after the patient died. In some cases, multiple prescriptions were filled on behalf of a single deceased person.
One Boston-area beneficiary had Medicare pay $1,200 for a prescription dispensed 25 days after his death, despite having no history of HIV in his Medicare record. A Miami pharmacy filled prescriptions for two separate deceased patients on the same day, collecting $1,800 for HIV drugs for individuals with no HIV diagnosis history. Investigators acknowledged they didn't know what happened to medications obtained on behalf of dead people, though some likely entered the underground prescription drug market.
Family Members' Warnings Ignored
Done Global prioritized profit over patient safety and public health by distributing over 40 million Adderall pills for non-legitimate medical purposes. Federal prosecutors emphasized this pattern of disregarding safety signals throughout the company's operations. The Justice Department noted Done provided dosages, directions, combinations or quantities of medications beyond legitimate medical purpose and without following usual professional practice.
Patients received prescriptions despite failing to meet DSM-V criteria for ADHD diagnosis, posing diversion risks, or showing clear contraindications for stimulant therapy. The systematic nature of these violations demonstrated corporate indifference to medical standards and patient welfare.
Federal Response and Law Enforcement Actions
Agencies Involved in the Investigation
The Done Health investigation mobilized multiple federal law enforcement agencies working in coordination. The Drug Enforcement Administration (DEA) led the controlled substance distribution aspects of the case. Assistant Administrator Cheri Oz of the DEA Diversion Control Division emphasized that by distributing over 40 million Adderall pills for non-legitimate medical purposes, Done prioritized profit over patient safety and public health.
The Department of Health and Human Services Office of Inspector General (HHS-OIG) contributed expertise on health care fraud. Deputy Inspector General for Investigations Christian J. Schrank stated that prescribing controlled substances without proper medical oversight endangers patients and erodes trust in the health care system. The Federal Bureau of Investigation and IRS Criminal Investigation also participated. Special Agent in Charge Harry T. Chavis of IRS Criminal Investigation noted that IRS agents are specially equipped to follow complex financial trails left by criminals.
Operation DisrupTor and Telehealth Enforcement
The Justice Department characterized the Done Global prosecution as its first criminal drug distribution case involving a digital health platform built around online Adderall subscriptions. This case arrived amid heightened federal scrutiny of telehealth prescribing practices.
Operation DisrupTor, though focused on darknet drug trafficking, demonstrated federal commitment to disrupting controlled substance distribution through technology platforms. That operation resulted in 179 arrests across Europe and the United States, with seizures exceeding $6.5 million in cash and virtual currencies. The broader telehealth enforcement landscape intensified in 2024 when DOJ charged 36 defendants for over $1.1 billion in fraudulent claims involving telemedicine and clinical laboratories.
Sentencing and Maximum Penalties Faced
He and Brody await sentencing scheduled for February 25, 2026. Done Global faces severe corporate penalties if convicted. The company confronts a maximum penalty of twice the gross profits or other proceeds for conspiracy and illegal distribution of Adderall charges. For conspiracy to commit health care fraud and obstruction, Done Global faces twice the gain or twice the gross loss. Mindful Mental Wellness faces a maximum penalty for conspiracy to illegally distribute Adderall of twice the gross profits or other proceeds.
Health Care Fraud Strike Force Program
The Fraud Section leads the Criminal Division's efforts to combat health care fraud through the Health Care Fraud Strike Force Program. Since March 2007, this program has charged more than 5,800 defendants who collectively billed federal health care programs and private insurers more than $30 billion. Strike Forces currently operate in 27 federal districts, bringing together HHS-OIG, DOJ, U.S. Attorneys' Offices, FBI, and local law enforcement. These teams analyze data and investigative intelligence to quickly identify fraud patterns and bring prosecutions.
Conclusion
The Done Health case demonstrates how quickly federal authorities will respond when telemedicine companies prioritize profit over patient safety. He and Brody's convictions send a clear message: exploiting regulatory loopholes to distribute controlled substances carries severe consequences, with both defendants facing decades in prison.
Telemedicine offers legitimate benefits for patients who need access to care. The problem arises when companies build automated prescription mills disguised as healthcare platforms. Done Global's $100 million scheme collapsed precisely because it abandoned medical standards for financial gain.
For the most part, federal agencies now scrutinize digital health companies more closely than ever before. Any platform prescribing controlled substances through telemedicine must establish genuine clinical oversight, conduct proper patient evaluations, and maintain rigorous safety protocols. The alternative means risking prosecution under multiple federal statutes with penalties that can destroy companies and send executives to prison.
References
[1] – https://oig.hhs.gov/fraud/strike-force/
[2] – https://www.ecfr.gov/current/title-21/chapter-II/part-1306
[3] – https://www.justice.gov/opa/pr/digital-health-company-and-medical-practice-indicted-100m-adderall-distribution-scheme
[4] – https://www.dea.gov/documents/2024/2024-06/2024-06-14/statement-dea-administrator-anne-milgram-done-global-inc
[5] – https://www.law.cornell.edu/uscode/text/21/829
[6] – https://www.federalregister.gov/documents/2023/03/01/2023-04248/telemedicine-prescribing-of-controlled-substances-when-the-practitioner-and-the-patient-have-not-had
[7] – https://www.fbi.gov/investigate/white-collar-crime/health-care-fraud
Need an Attorney? CALL NOW: 213-932-8922
Yuliya Kelmansky is an Expert Attorney who has over 10 years of practice defending a variety of cases.
